| Target Professions: | DO, MD, Physician Assistant, Nurse Practitioner |
| Target Specialties: | Neurology, Epileptology, Pediatrics |
| Credits Available: | 4.25 AMA PRA Category 1 Credit™/ MOC Points |
This curriculum is designed to empower neurologists and epileptologists with the knowledge to address the unique challenges posed by Developmental and Epileptic Encephalopathies (DEEs). Through a blend of self-study modules, live discussions, and action planning, participants will learn to optimize care for DEE patients by understanding the impact of anti-seizure medications on both seizure and non-seizure symptoms.
Please answer the following questions to assess your understanding of non-seizure symptoms in patients with developmental and epileptic encephalopathies.
This module gives an overview of DEEs and their non-seizure symptoms, and why these symptoms are important to manage.
This module discusses the major anti-seizure medicines used for patients with DEEs and how they impact the non-seizure symptoms of these disorders.
This module discusses the importance of individualizing care for patients with DEEs and reviews the non-pharmaceutical interventions for these patients.
Now that you have reviewed the self-study modules, answer the following questions to assess your understanding of non-seizure symptoms in patients with developmental and epileptic encephalopathies (DEEs).
This discussion focuses on the identification and clinical significance of non-seizure symptoms in DEEs, emphasizing how these symptoms affect patient quality of life and treatment decisions.
This activity features a boy with LGS who is sleepy at school. In this patient case activity, you will discuss possible reasons for his sleepiness, anti-seizure meds and side effects, and monitoring patients with DEEs.
This activity features a girl with tuberous sclerosis who is having some behavioral changes that concern her family. The activity discusses ways to approach the dynamic situation that patients with various DEEs can present.
In light of the information reviewed and discussed during this program, please share an action plan that you will implement to improve the diagnosis and management for your patients with Developmental and Epileptic Encephalopathies (DEEs).
This discussion explores the therapeutic impact of newer anti-seizure medications on non-seizure symptoms in DEEs and strategies for individualized patient care.
